Sign inJoin waitlistJoin the waitlist

FL

Frank Lieberman

Director, Adult Neuro-Oncology Program, UPMC Hillman Cancer Center · UPMC Medical Education

Credentials: · ·

History

Adult Neuro-Oncology Program · UPMC Medical Education
Present
UPMC Medical Education
Present

Neurology
1980–1984
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1975–1979

Research

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
JAMA · 2017 · 2,133 citations
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
JAMA · 2015 · 1,013 citations
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and…
Journal of Clinical Oncology · 2011 · Last of 20 authors · 475 citations

PW
Patrick Wen
31 papers
Michael Prados
26 papers
Jan Drappatz
25 papers
HR
H Robins
24 papers
Minesh Mehta
24 papers
Susan Chang
23 papers
Timothy Cloughesy
22 papers
LD
Lisa DeAngelis
20 papers
Kenneth Aldape
16 papers
James Mountz
15 papers
LA
Lauren Abrey
15 papers
SG
Stuart Grossman
14 papers

Grants

NABTC Member Institution Grant (UCSF Project Leader)
National Cancer Institute · U01
Contact PI · $434.9K · University of Pittsburgh at Pittsburgh
1994–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $27.1K · University of Pittsburgh at Pittsburgh
2004–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $204.3K · Icahn School of Medicine at Mount Sinai
1997–2001

Clinical trials

Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
Principal investigator · Completed · Early phase 1
Frank Lieberman
2012–2018
HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
Principal investigator · Completed · Early phase 1
Ian F. Pollack, M.D.
2009–2013
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
Principal investigator · Completed · Early phase 1
Ian F. Pollack, M.D.
2009–2015
Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas
Principal investigator · Completed · Phase 1, Phase 2
Frank Lieberman
2006–2016